Primary Care Physician

The petitioner proposes to continue research in microbiology focused on discovering antimicrobial agents and elucidating their mechanisms to combat multidrug-resistant bacteria. The work involves developing phage therapies, nanoparticle-drug hybrids, and innovative antimicrobial delivery systems to replace or augment conventional antibiotics. This endeavor aims to address the global healthcare emergency of antibiotic resistance and improve drug treatment efficacy.

The petitioner proposes to continue her research in biomedical science, specifically focusing on advancing the understanding of mechanisms behind deadly diseases such as cholera, Salmonella, and COVID-19. Her work involves characterizing complex factors in antibiotic production and resistance to accelerate the development of novel, therapeutically effective antibiotics. The research aims to mitigate the threat of bacterial infections and minimize the prevalence and mortality of infectious diseases in the United States.

The petitioner proposes to design and develop novel antimicrobial compounds for in vitro and in vivo applications to combat resistant pathogens and bridge the gap between basic discovery and clinical translation.

The petitioner proposes to develop vaccines using advanced molecular biology and immunological approaches to target bacterial pathogens resistant to standard antibiotics. The work specifically focuses on Neisseria gonorrhoeae, a major antimicrobial resistance threat in the U.S., to create novel vaccine design strategies.